+

WO2006108491A1 - Improved process for preparing oxazole nitriles - Google Patents

Improved process for preparing oxazole nitriles Download PDF

Info

Publication number
WO2006108491A1
WO2006108491A1 PCT/EP2006/002509 EP2006002509W WO2006108491A1 WO 2006108491 A1 WO2006108491 A1 WO 2006108491A1 EP 2006002509 W EP2006002509 W EP 2006002509W WO 2006108491 A1 WO2006108491 A1 WO 2006108491A1
Authority
WO
WIPO (PCT)
Prior art keywords
oxazole
formula
chloride
phase
nitriles
Prior art date
Application number
PCT/EP2006/002509
Other languages
French (fr)
Inventor
Johann Hiebl
Michael Stanek
Jan Hilko Schulte
Original Assignee
Dsm Fine Chemicals Austria Nfg Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Fine Chemicals Austria Nfg Gmbh & Co Kg filed Critical Dsm Fine Chemicals Austria Nfg Gmbh & Co Kg
Publication of WO2006108491A1 publication Critical patent/WO2006108491A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Definitions

  • Oxazole nitriles such as, for instance, 2- (5-methyl-2- phenyl-1, 3-oxazol-4-yl) acetonitrile, are valuable intermediates in the synthesis of pharmaceuticals which are employed for example for the prophylaxis and/or treatment of diabetes II .
  • the present invention accordingly relates to an improved process for preparing oxazole nitriles of the formula
  • Oxazole nitriles of the formula (I) are prepared by the process of the invention.
  • Ar is aryl or heteroaryl and Rl is H or alkyl .
  • Aryl and heteroaryl mean in this connection aromatic compounds which preferably have 4 to 20 C atoms.
  • the heteroaryl compounds additionally have 1 to 3 heteroatoms from the group of 0, N or S .
  • Possibilities in this connection are monocyclic or polycyclic aromatic groups to which further rings (cycloalkyl, cycloheteroalkyl or heteroaryl) may be fused where appropriate .
  • aromatic compounds examples include phenyl, naphthyl, cyclopentadienyl, indenyl , fluorenyl, indanyl, tetralinyl, pyrrolyl, furyl, thienyl, pyridyl, pyrimidinyl, indolyl, cumaronyl, quinolinyl, chromenyl , chromanyl, etc.
  • aryl means phenyl or naphthyl and heteroaryl pyridyl .
  • the aryl and heteroaryl radicals may moreover be optionally substituted one or more times.
  • suitable substituents are alkyl, preferably Ci-C 3 -alkyl, alkoxy, preferably Ci-C 6 -alkoxy, halogen such as, for instance, chlorine, bromine or fluorine, mono- or polyhaloalkyl , mono- or polyhaloalkoxy, alkenyl , preferably C 2 -C 8 -alkenyl, optionally substituted phenyl, optionally substituted amine, hydroxy, nitro, carboxyl, carboxylic ester, etc.
  • the aryl or heteroaryl radical is preferably unsubstituted or substituted once or twice by hydroxy, Ci-C 4 -alkyl, C 1 -C 4 -alkoxy, chlorine, trifluoromethyl or phenyl .
  • Rl is H or alkyl, where alkyl means saturated or mono- or polyunsaturated, linear, branched or cyclic hydrocarbon chains having 1 to 20 C atoms, preferably having 1 to 8 C atoms. Examples thereof are methyl, ethyl, i-propyl, tert-butyl, cyclohexyl, propenyl, etc.
  • the inventive preparation of the oxazole nitriles of the formula (I) starts from the corresponding oxazole chloride of the formula (II) .
  • Suitable oxazole chlorides can be prepared as in the prior art as described, for instance, in Chem. Pharm. Bull., 1971, 19, pp. 2050; J. Med. Chem., 1996, 39, pp. 237-245; J. Med. Chem., 2000, 43, p. 995-1010, US 5468760, US 5480896, WO 03/043985, etc.
  • the inventive reaction of the oxazole chlorides of the formula (II) to give the desired oxazole nitriles of the formula (I) takes place in a suitable solvent with an alkali metal cyanide in the presence of a phase- transfer catalyst .
  • Suitable solvents for the inventive process are aromatic hydrocarbons, which may be optionally halogenated, such as, for instance, toluene, xylenes, chlorobenzenes, etc., or mixtures thereof with water.
  • aromatic hydrocarbons which may be optionally halogenated, such as, for instance, toluene, xylenes, chlorobenzenes, etc., or mixtures thereof with water.
  • a mixture of toluene and water is preferably employed as solvent .
  • alkali metal cyanide Suitable examples of alkali metal cyanide are NaCN, LiCN, KCN, etc.
  • the cyanide is in this case employed in at least the equivalent amount or in an excess relative to the oxazole chloride.
  • the cyanide is preferably used in an amount of from 1.0 to 2.5 mol per mol of oxazole chloride and particularly preferably from 1.1 to 1.5 mol per mol of oxazole chloride .
  • Suitable phase-transfer catalysts are quaternary phosphonium salts such as, for instance, (alkyl) 4 P + Hal " , (aryl) 4 P + Hal ⁇ , alkylaryl-P + HaI " , etc. or quaternary ammonium salts such as, for instance, tetraalkylammonium halides, tetraarylammonium halides, alkylarylammonium halides or cyanides, etc., which are described for example in CM. Starks, CL. Liotta, M. C. Halpern, Phase Transfer Catalysis; Chapman & Hall; New York, 1994.
  • Halide means in this case preferably bromide or chloride.
  • the tetraalkyl moiety consists of four alkyl groups, which may be identical or different, and comprise 1 to 16 C atoms.
  • the aryl moiety may be for example phenyl or benzyl .
  • Quaternary ammonium salts are preferably employed.
  • phase-transfer catalysts examples include tetrabutylammonium bromide (TBAB) , tributylmethyl- ammonium chloride (TBMAC) , trimethylbenzylammonium chloride, etc.
  • phase-transfer catalyst is employed in the inventive reaction in an amount of from 0.001 to 0.1 mol per mol of oxazole chloride. An amount of from 0.01 to 0.05 mol per mol of oxazole chloride is preferred.
  • the reaction temperature is 50 to 120 0 C, preferably 75 to 90 0 C.
  • reagents oxazole chloride, solvent, cyanide, phase-transfer catalyst
  • the cyanide can also be added last, at the desired reaction temperature.
  • the reaction mixture is cooled to a temperature of from 5 to 30 0 C, preferably to 15 to 25°C, and an aqueous base such as, for instance, a dilute Na 2 CO 3 or NaHCO 3 solution is added and, after phase separation, the organic phase is, where appropriate after extraction one or more times with the aqueous base, concentrated.
  • suitable solvents for this are diisopropyl ether, tert-butyl methyl ether, methanol, etc.
  • Oxazole nitriles of the formula (I) are prepared in higher yields compared with the prior art, and in high purity, from easily obtainable precursors in a simple manner which is easy to achieve industrially.
  • Ar is aryl or heteroaryl
  • Rl is H or alkyl
  • R2 is alkyl or aryl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

An improved process for preparing oxazole nitriles of formula (I) in which Ar is aryl or heteroaryl and Rl is H or alkyl , which comprises reacting a corresponding oxazole chloride of formula (II) in which Ar and Rl are as defined above, in a solvent with an alkali metal cyanide in the presence of a phase-transfer catalyst to give the desired oxazole nitrile of formula (I) .

Description

Improved process for preparing oxazole nitriles
Oxazole nitriles such as, for instance, 2- (5-methyl-2- phenyl-1, 3-oxazol-4-yl) acetonitrile, are valuable intermediates in the synthesis of pharmaceuticals which are employed for example for the prophylaxis and/or treatment of diabetes II .
The use of such oxazole nitriles for preparing active pharmaceutical ingredients is disclosed for example in US 6,673,815. In Example 4 of the US patent, 2- (5- πiethyl-2 -phenyl- 1, 3-oxazol-4-yl) acetonitrile is obtained in a yield of 37% from the corresponding chloride by reaction with NaCN in DMSO. The chloride is in this case obtained according to Malamas et al . , J. Med. Chem. 39 (1) , 1996; 237-245, by reacting the corresponding benzaldehyde with 2 , 3-butanedione monoxime and subsequent deoxygenation with phosphorus oxychloride . In WO 02/092084 too, the corresponding chloride is reacted with NaCN in DMSO to give the nitrile. Once again, the yield is very low, not exceeding 50%. According to J. Med. Chem. 2001, 44, pp. 2061-2064, the chloride is reacted with KCN in the presence of KI in DMF to give the desired nitrile. The disadvantage in this case is the use of the costly auxiliary reagent KI.
A further possibility for preparing the nitriles is, according to US 6,673,815, reaction of the corresponding alcohol in accordance with the reference Aesa et al . , Synth. Commun. 1996, 26(5), 909-914 with acetone cyanohydrin in the presence of triphenylphosphine-diethyl azodicarboxylate .
It was an object of the present invention to find an improved process for preparing oxazole nitriles which starts from easily and inexpensively obtainable starting materials, which enables reaction in an efficient and industrially achievable manner and easy purification of the reaction mixture, which affords the desired oxazole nitrile in higher yields.
The present invention accordingly relates to an improved process for preparing oxazole nitriles of the formula
Figure imgf000003_0001
in which Ar is aryl or heteroaryl and Rl is H or alkyl, which comprises reacting a corresponding oxazole chloride of the formula
Figure imgf000003_0002
in which Ar and Rl are as defined above, in a solvent with an alkali metal cyanide in the presence of a phase-transfer catalyst to give the desired oxazole nitrile of the formula (I) .
Oxazole nitriles of the formula (I) are prepared by the process of the invention.
In the formula (I) Ar is aryl or heteroaryl and Rl is H or alkyl . Aryl and heteroaryl mean in this connection aromatic compounds which preferably have 4 to 20 C atoms. The heteroaryl compounds additionally have 1 to 3 heteroatoms from the group of 0, N or S . Possibilities in this connection are monocyclic or polycyclic aromatic groups to which further rings (cycloalkyl, cycloheteroalkyl or heteroaryl) may be fused where appropriate . Examples of such aromatic compounds are phenyl, naphthyl, cyclopentadienyl, indenyl , fluorenyl, indanyl, tetralinyl, pyrrolyl, furyl, thienyl, pyridyl, pyrimidinyl, indolyl, cumaronyl, quinolinyl, chromenyl , chromanyl, etc.
Preferably aryl means phenyl or naphthyl and heteroaryl pyridyl .
The aryl and heteroaryl radicals may moreover be optionally substituted one or more times. Examples of suitable substituents are alkyl, preferably Ci-C3-alkyl, alkoxy, preferably Ci-C6-alkoxy, halogen such as, for instance, chlorine, bromine or fluorine, mono- or polyhaloalkyl , mono- or polyhaloalkoxy, alkenyl , preferably C2-C8-alkenyl, optionally substituted phenyl, optionally substituted amine, hydroxy, nitro, carboxyl, carboxylic ester, etc.
The aryl or heteroaryl radical is preferably unsubstituted or substituted once or twice by hydroxy, Ci-C4-alkyl, C1-C4-alkoxy, chlorine, trifluoromethyl or phenyl .
Rl is H or alkyl, where alkyl means saturated or mono- or polyunsaturated, linear, branched or cyclic hydrocarbon chains having 1 to 20 C atoms, preferably having 1 to 8 C atoms. Examples thereof are methyl, ethyl, i-propyl, tert-butyl, cyclohexyl, propenyl, etc.
The inventive preparation of the oxazole nitriles of the formula (I) starts from the corresponding oxazole chloride of the formula (II) .
Ar and Rl in formula (II) are as defined above.
Suitable oxazole chlorides can be prepared as in the prior art as described, for instance, in Chem. Pharm. Bull., 1971, 19, pp. 2050; J. Med. Chem., 1996, 39, pp. 237-245; J. Med. Chem., 2000, 43, p. 995-1010, US 5468760, US 5480896, WO 03/043985, etc. It is particularly advantageous to purify the oxazole chloride, after the reaction of the corresponding oxazole N-oxide with POCl3 as in the prior art, by- extraction with water and, where appropriate, recrystallization in methanol or a methanol/water mixture, because the purity of the product can be increased considerably thereby in an efficient and industrially achievable manner.
The inventive reaction of the oxazole chlorides of the formula (II) to give the desired oxazole nitriles of the formula (I) takes place in a suitable solvent with an alkali metal cyanide in the presence of a phase- transfer catalyst .
Suitable solvents for the inventive process are aromatic hydrocarbons, which may be optionally halogenated, such as, for instance, toluene, xylenes, chlorobenzenes, etc., or mixtures thereof with water. A mixture of toluene and water is preferably employed as solvent .
Suitable examples of alkali metal cyanide are NaCN, LiCN, KCN, etc.
The cyanide is in this case employed in at least the equivalent amount or in an excess relative to the oxazole chloride.
The cyanide is preferably used in an amount of from 1.0 to 2.5 mol per mol of oxazole chloride and particularly preferably from 1.1 to 1.5 mol per mol of oxazole chloride .
Suitable phase-transfer catalysts are quaternary phosphonium salts such as, for instance, (alkyl) 4P+Hal", (aryl) 4P+Hal~, alkylaryl-P+HaI", etc. or quaternary ammonium salts such as, for instance, tetraalkylammonium halides, tetraarylammonium halides, alkylarylammonium halides or cyanides, etc., which are described for example in CM. Starks, CL. Liotta, M. C. Halpern, Phase Transfer Catalysis; Chapman & Hall; New York, 1994. Halide means in this case preferably bromide or chloride. The tetraalkyl moiety consists of four alkyl groups, which may be identical or different, and comprise 1 to 16 C atoms. The aryl moiety may be for example phenyl or benzyl .
Quaternary ammonium salts are preferably employed.
Examples of suitable phase-transfer catalysts are tetrabutylammonium bromide (TBAB) , tributylmethyl- ammonium chloride (TBMAC) , trimethylbenzylammonium chloride, etc.
The phase-transfer catalyst is employed in the inventive reaction in an amount of from 0.001 to 0.1 mol per mol of oxazole chloride. An amount of from 0.01 to 0.05 mol per mol of oxazole chloride is preferred.
The reaction temperature is 50 to 1200C, preferably 75 to 900C.
To carry out the process, preferably all the reagents (oxazole chloride, solvent, cyanide, phase-transfer catalyst) are introduced simultaneously and then heated to the desired temperature, preferably while stirring. Alternatively, the cyanide can also be added last, at the desired reaction temperature. After the reaction is complete, the reaction mixture is cooled to a temperature of from 5 to 300C, preferably to 15 to 25°C, and an aqueous base such as, for instance, a dilute Na2CO3 or NaHCO3 solution is added and, after phase separation, the organic phase is, where appropriate after extraction one or more times with the aqueous base, concentrated. The remaining residue is recrystallized where appropriate in a suitable solvent. Examples of suitable solvents for this are diisopropyl ether, tert-butyl methyl ether, methanol, etc.
Oxazole nitriles of the formula (I) are prepared in higher yields compared with the prior art, and in high purity, from easily obtainable precursors in a simple manner which is easy to achieve industrially.
The oxazole nitriles of the formula (I) which are prepared according to the invention are moreover outstandingly suitable for further reaction to give the corresponding oxazole carboxylic esters of the formula
Figure imgf000007_0001
in which Ar is aryl or heteroaryl, Rl is H or alkyl and R2 is alkyl or aryl, for example by converting the appropriate oxazole nitrile into the desired oxazole carboxylic esters in the presence of a mineral acid and of an alcohol of the formula R20H and subsequent hydrolysis with water.
Example 1: Preparation of 2- (5-methyl-2 -phenyl-I73- oxazol-4-yl) acetonitrile
a) Preparation of the oxazole chloride
1465 g (13.8 mol) of benzaldehyde, 1244 g (12.3 mol) of 2,3-butanedione monoxime and 4.8 1 of cone, acetic acid were mixed and this mixture was cooled to 40C while stirring. Then, over the course of 100 min, 1500 g (41.1 mol) of HCl gas were passed in at an internal temperature of 4-120C. The reaction mixture was stirred at the same temperature for 1 h and then, at 10-200C, 21 1 of t-butyl methyl ether (MTBE) were added over the course of 45 min. The MTBE addition was initially exothermic. The mixture was then stirred at 50C for a further 30 min and subsequently the resulting solid was filtered off. The solid was washed with MTBE and dried in vacuo at 5O0C. Yield: 2498 g of oxazole N-oxide (11.07 mol, 90%).
2220 g of oxazole N-oxide were suspended in 19.9 1 of methylene chloride, and this mixture was cooled to 5°C. Then, over the course of 15 min, 2837 g (18.5 mol) of POCl3 were added at an internal temperature of 5-70C. Stirring at 5-70C for 3.0 min was followed by slow warming to 400C and stirring at this temperature for 3 h. After cooling to 50C, 34.7 1 of water were added over the course of 2 h. The phases were separated and the organic phase was extracted with 17.3 1 of water.
The organic phase was concentrated in vacuo, and the residue was recrystallized from methanol/water
(14.4 1/14.4 1) and washed with 10 1 of water. Filtration and drying resulted in 1940 g (9.35 mol, 95%) of the oxazole chloride.
b) Reaction of the oxazole chloride
1634 g (7.87 mol) of oxazole chloride, 463 g (9.44 mol) of NaCN, 28 g (0.119 mol) of tributylmethylammonium chloride, 4.9 1 of toluene and 0.24 1 of H2O were introduced into the reactor, and this mixture was heated at 80-85°C while stirring vigorously for 6 h. After the reaction mixture had cooled to 200C, dilute aqueous Na2CO3 solution was added and, after phase separation, the organic phase was extracted twice with dilute aqueous Na2CO3 solution. The residue after concentration of the organic phase in vacuo was dissolved in diisopropyl ether, filtered through activated carbon and crystallized. 1435 g (7.24 mol, 92%) of the oxazole nitrile were obtained.

Claims

Claims :
1. An improved process for preparing oxazole nitriles of the formula
Figure imgf000009_0001
in which Ar is aryl or heteroaryl and Rl is H or alkyl , which comprises reacting a corresponding oxazole chloride of the formula
Figure imgf000009_0002
in which Ar and Rl are as defined above, in a solvent with an alkali metal cyanide in the presence of a phase-transfer catalyst to give the desired oxazole nitrile of the formula (I) .
2. The process as claimed in claim 1, wherein the reaction takes place in a solvent from the group of optionally halogenated aromatic hydrocarbons or in a mixture thereof with water.
3. The process as claimed in either of claims 1 or 2 , wherein the cyanide is employed in an amount of from 1.0 to 2.5 mol per mol of oxazole chloride .
4. The process as claimed in any of claims 1 to 3 , wherein a quaternary phosphonium salt or a quaternary ammonium salt is employed as phase- transfer catalyst .
5. The process as claimed in any of claims 1 to 4, wherein the phase-transfer catalyst is employed in an amount of from 0.001 to 0.1 mol per mol of oxazole chloride .
6. The process as claimed in any of claims 1 to 5, wherein the reaction is carried out at from 50 to 12O0C.
7. The process as claimed in any of claims 1 to 6, wherein the oxazole nitrile of the formula (I) is isolated by adding, after the reaction has taken place, an aqueous base to the reaction mixture, after which a phase separation takes place, the organic phase is, where appropriate after extraction with the aqueous base, concentrated, and the remaining residue is recrystallized where appropriate.
8. The process as claimed in any of claims 1 to 7, wherein the chloride of the formula (II) employed is prepared by reacting the corresponding oxazole N-oxide with POCl3, extracting with water and, where appropriate, subsequently recrystallizing in methanol or a methanol/water mixture.
9. The use of oxazole nitriles of the formula (I) prepared as claimed in any of claims 1 to 8 for preparing oxazole carboxylic esters of the formula
Figure imgf000010_0001
in which Ar is aryl or heteroaryl, Rl is H or alkyl and R2 is alkyl or aryl .
10. The use as claimed in claim 9, wherein an appropriate oxazole nitrile of the formula (I) is converted into the desired oxazole carboxylic ester of the formula (II) in the presence of a mineral acid and of an alcohol of the formula R2OH and subsequent hydrolysis with water.
PCT/EP2006/002509 2005-04-11 2006-03-18 Improved process for preparing oxazole nitriles WO2006108491A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ATA598/2005 2005-04-11
AT5982005 2005-04-11

Publications (1)

Publication Number Publication Date
WO2006108491A1 true WO2006108491A1 (en) 2006-10-19

Family

ID=36570918

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/002509 WO2006108491A1 (en) 2005-04-11 2006-03-18 Improved process for preparing oxazole nitriles

Country Status (1)

Country Link
WO (1) WO2006108491A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012153331A2 (en) 2011-05-09 2012-11-15 Topical Therapeutic Agent (Tta) Ltd. Nitric oxide-sequestering topical formulations

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1139940A (en) * 1966-09-30 1969-01-15 Ici Ltd Oxazole derivatives
US4661610A (en) * 1985-07-31 1987-04-28 Basf Aktiengesellschaft Preparation of veratryl cyanide
WO2002018355A1 (en) * 2000-08-23 2002-03-07 Eli Lilly And Company Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists
US20030055265A1 (en) * 2001-05-15 2003-03-20 Alfred Binggeli Oxazole derivatives

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1139940A (en) * 1966-09-30 1969-01-15 Ici Ltd Oxazole derivatives
US4661610A (en) * 1985-07-31 1987-04-28 Basf Aktiengesellschaft Preparation of veratryl cyanide
WO2002018355A1 (en) * 2000-08-23 2002-03-07 Eli Lilly And Company Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists
US20030055265A1 (en) * 2001-05-15 2003-03-20 Alfred Binggeli Oxazole derivatives

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BROOKS D A ET AL: "Design and synthesis of 2-methyl-2-{4-[2-(5-methyl-2- aryloxazol-4-yl)ethoxy]phenoxy}propionic acids: a new class of dual PPARalpha/gamma agonists", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, vol. 44, no. 13, 21 June 2001 (2001-06-21), pages 2061 - 2064, XP002184099, ISSN: 0022-2623 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012153331A2 (en) 2011-05-09 2012-11-15 Topical Therapeutic Agent (Tta) Ltd. Nitric oxide-sequestering topical formulations

Similar Documents

Publication Publication Date Title
RU2593752C1 (en) Compounds applicable for synthesis of benzamide compounds
Guchhait et al. One-pot preparation of isocyanides from amines and their multicomponent reactions: crucial role of dehydrating agent and base
KR101472686B1 (en) Method for preparation of benzimidazole derivatives
EA036663B1 (en) Method for preparing azoxystrobin
RU2650110C2 (en) Processes for synthesis of 2-amino-4,6-dimethoxybenzamide and other benzamide compounds
CN110256451B (en) Synthetic method of benzofuro [2,3-b ] quinoline derivative
CN115197261B (en) Synthesis method of oxadiazine boron derivative
WO2006108491A1 (en) Improved process for preparing oxazole nitriles
CN101475536A (en) Polysubstituted S-DACO derivative, synthesizing method and use thereof
WO2017081702A2 (en) A process for preparation of enzalutamide
JP5033933B2 (en) Process for producing N-substituted-2-amino-4- (hydroxymethylphosphinyl) -2-butenoic acid
KR20190049883A (en) Method for producing phenylalanine compound
CN107954960B (en) A kind of synthetic method of 1,3-dihydroisobenzofuran compounds
CN112661668A (en) N-substituted amide compound and preparation method thereof
CN112979632A (en) Synthesis method of 4-hydroxy-1, 3-thiazine-2-thioketone compound
JP5334435B2 (en) Method for producing optically active aminoacetal derivative
CN110746337B (en) Synthesis method of 1-methyl-2-cyano-3-aliphatic substituted azole compound
CN100389110C (en) A kind of method for preparing aromatic ring substituted isoxazoline compounds
JP5142241B2 (en) Method for producing nicotinic acid ester compound
JP4032861B2 (en) Process for producing β-oxonitrile derivative or alkali metal salt thereof
MXPA02001248A (en) Process for the preparation of acylated 1,3-dicarbonyl compounds.
Kim et al. Organozinc reagents for facile synthetic route to Diflunisal, Fenbufen and Felbinac
WO2007086559A1 (en) Method for producing tetrahydropyran compound
JP4663105B2 (en) Method for producing 2-sulfonyl-4-oxypyridine derivative
KR101354175B1 (en) Method of preparing methyl (e)-2-(3-methoxy)acrylate from 2-(3,3-demethoxy)propanoate

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

NENP Non-entry into the national phase

Ref country code: RU

WWW Wipo information: withdrawn in national office

Country of ref document: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06707606

Country of ref document: EP

Kind code of ref document: A1

点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载